Riverside Rest Home in Dover, NH

Riverside Rest Home is a medicare and medicaid certified nursing home in Dover, New Hampshire. It is located in Strafford county at 276 County Farm Road, Dover, New Hampshire 03820. You can reach out to the office of Riverside Rest Home via phone at (603) 742-1348. This skilled nursing facility has 215 federally certified beds with average occupancy rate of 63.44%. Its legal business name is County Of Strafford and has the following ownership type - Government - County.

Riverside Rest Home (Medicare CCN 305047) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1995 (29 years certified) and the last quality survey was conducted in March, 2020.

Name	Riverside Rest Home
Location	276 County Farm Road, Dover, New Hampshire
Certified By	Medicare and Medicaid
No. of Certified Beds	215
Occupancy Rate	63.44%
Medicare ID (CCN)	305047
Legal Business Name	County Of Strafford
Ownership Type	Government - County

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Riverside Rest Home from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Riverside Rest Home are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Riverside Rest Home give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Insufficient placental steroid may increase autism spectrum disorder risk

A study in experimental models suggests that allopregnanolone, one of many hormones produced by the placenta during pregnancy, is so essential to normal fetal brain development that when provision of that hormone decreases or stops abruptly - as occurs with premature birth - offspring are more likely to develop autism-like behaviors.

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

SMER28 can reduce beta-amyloid accumulation in patients with Alzheimer's disease

If you can't stop the beta-amyloid protein plaques from forming in Alzheimer's disease patients, then maybe you can help the body rid itself of them instead. At least that's what scientists from New York were hoping for when they found a drug candidate to do just that.

Young refugees have greater risk of developing mental disorders

War, torture, human trafficking and extreme poverty are just some of the appalling experiences to which refugees are exposed, both before and during their flight. Experiences such as these put those affected at risk of mental illness, even years afterwards.

Merck, Idera Pharmaceuticals extend their vaccine research collaboration

Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the companies entered into an exclusive license and research collaboration agreement to research, develop, and commercialize vaccine products containing the Company's investigational agonist compounds targeting Toll-like Receptors (TLRs) 7, 8, and 9 in the fields of oncology, infectious diseases, and Alzheimer's disease.

Read more Medical News

› Verified 4 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Riverside Rest Home is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	21.94	14.46
Percentage of long-stay residents who lose too much weight	5.64	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	52.46	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	0.95	1.79
Percentage of long-stay residents with a urinary tract infection	1.15	2.65
Percentage of long-stay residents who have depressive symptoms	2.77	5.05
Percentage of long-stay residents who were physically restrained	3.58	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	3.86	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	98	93.87
Percentage of long-stay residents who received an antipsychotic medication	40.55	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	28.75	83.88